Stryker recently completed a $764 million acquisition of Chinese-based orthopedic developer Trauson Holdings Company Limited and has its sights set on more acquisitions in the near future, according to Michigan Live. 
Company CEO Kevin Lobo spoke at the Bank of America Merrill Lynch 2013 Health Care Conference this week. He said he's most excited about orthopedic and spine sector growth, including the "huge unmet needs" in the spine market, according to the report.
He said Stryker has an "appetite to do more acquisitions," according to the report. Stryker also acquired Orthovita bone graft materials in 2011 and Surpass, an Israel-based stent company, in 2012.
More Articles on Devices:
Accellent Suffers $62.1M New Loss in Q1
United Surgical Partners International Files 59.5% Q1 Drop in Net Income
35 Orthopedic & Spine Devices Receive FDA 510(k) Clearance
Company CEO Kevin Lobo spoke at the Bank of America Merrill Lynch 2013 Health Care Conference this week. He said he's most excited about orthopedic and spine sector growth, including the "huge unmet needs" in the spine market, according to the report. He said Stryker has an "appetite to do more acquisitions," according to the report. Stryker also acquired Orthovita bone graft materials in 2011 and Surpass, an Israel-based stent company, in 2012.
More Articles on Devices:
Accellent Suffers $62.1M New Loss in Q1
United Surgical Partners International Files 59.5% Q1 Drop in Net Income
35 Orthopedic & Spine Devices Receive FDA 510(k) Clearance